The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, No. 45 (Nov. 7, 2006), pp. 16900-16905 (6 pages) GPIbα binding to von Willebrand factor (VWF) exposed at a ...

Researchers have identified serine threonine kinase 10 as a key regulator of platelet function, haemostasis and ...

During the past decade, extensive research has focused on the role of platelets in cardiovascular disorders, and antiplatelet drugs have become the mainstay of therapy for its treatment. Although ...

Approximately 40% of adolescent women experience heavy menstrual bleeding (HMB), and 10–62% of them have an underlying bleeding disorder (BD). Diagnosing a BD remains challenging because of ...

A recently described hemorrhagic disorder characterized by defective platelet aggregation induced by collagen and epinephrine appears to be caused, in part, by the same abnormality induced by aspirin ...

When cancer cells and platelets mix, the risk of metastasis and cancer-related deep vein thrombosis (DVT) and pulmonary embolism (PE) increases, but a small, proof-of-concept study suggests that the ...

Severe malaria is characterized by the sequestration of Plasmodium falciparutnr-infected erythrocytes (IBs). Because platelets can affect tumor necrosis factor (TNF)-activated endothelial cells (ECs), ...

Platelets are small types of blood cells that prevent excessive bleeding. It’s possible to develop low or high platelet counts related to a number of health conditions. Platelets are one of the main ...